Eslicarbazepine acetate: a guide to its use as adjunctive therapy in partial-onset seizures

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 10, 2011-10 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Effect of Food on the Pharmacokinetic Profile of Eslicarbazepine Acetate (BIA 2-093)

By Maia Joana   Vaz-da-Silva Manuel   Almeida Luis   Falcão Amilcar   Silveira Pedro   Guimarães Serafim   Graziela Patricia   Soares-da-Silva Patricio  

Drugs in R&D, Vol. 6, Iss. 4, 2005-01 ,pp. : 201-206

Adis International

Access to resources Recommend Favorite

Dosage Form Proportionality and Food Effect of the Final Tablet Formulation of Eslicarbazepine Acetate: Randomized, Open-Label, Crossover, Single-Centre Study in Healthy Volunteers

By Fontes-Ribeiro Carlos  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 447-454

Adis International

Access to resources Recommend Favorite

Pharmacokinetics, Drug Interactions and Exposure-Response Relationship of Eslicarbazepine Acetate in Adult Patients with Partial-Onset Seizures: Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses

By Falcão Amilcar   Fuseau Eliane  

CNS Drugs, Vol. 26, Iss. 1, 2012-01 ,pp. : 79-91

Adis International

Access to resources Recommend Favorite

Eslicarbazepine Acetate (BIA 2-093): Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations

By Fontes-Ribeiro Carlos  

Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite